We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
NetEase
NTES
$76.5B
| $7.99M | 0.03% |
158,110
-36,235
| -19% | -$1.85M |
|
502
Crown Castle
CCI
$31.2B
| $7.96M | 0.03% |
73,796
+419
| +0.6% | +$43.5K |
|
|
CVSA
503
Covista Inc
CVSA
$4.3B
| $7.92M | 0.03% |
164,600
-13,000
| -7% | -$622K |
|
504
Celanese
CE
$5.18B
| $7.86M | 0.03% |
70,794
-235
| -0.3% | -$25.9K |
|
505
Credit Acceptance
CACC
$6.23B
| $7.84M | 0.03% |
22,200
+9,300
| +72% | +$3.19M |
|
506
Mettler-Toledo International
MTD
$26.7B
| $7.81M | 0.03% |
13,506
-6,428
| -32% | -$3.67M |
|
507
Credicorp
BAP
$29.6B
| $7.8M | 0.03% |
34,639
-4,482
| -11% | -$1.02M |
|
508
Travelers Companies
TRV
$78.8B
| $7.78M | 0.03% |
63,628
-1,900
| -3% | -$249K |
|
|
ARRY
509
DELISTED
Array Biopharma Inc
ARRY
| $7.74M | 0.03% |
461,486
-118,187
| -20% | -$1.88M |
|
510
Nutrien
NTR
$37.6B
| $7.64M | 0.03% |
140,475
+6,338
| +5% | +$314K |
|
511
Aclaris Therapeutics
ACRS
$814M
| $7.63M | 0.03% |
381,948
+87,250
| +30% | +$1.61M |
|
512
RingCentral
RNG
$6.05B
| $7.61M | 0.03% |
108,200
+12,100
| +13% | +$866K |
|
513
Sabra Healthcare REIT
SBRA
$5.18B
| $7.61M | 0.03% |
350,033
-180,310
| -34% | -$3.52M |
|
514
Supernus Pharmaceuticals
SUPN
$2.4B
| $7.57M | 0.03% |
126,395
-60,056
| -32% | -$3.11M |
|
515
Diamondrock Hospitality Co
DRH
$2.54B
| $7.53M | 0.03% |
613,392
-136,159
| -18% | -$1.59M |
|
|
SRCI
516
DELISTED
SRC Energy Inc
SRCI
| $7.5M | 0.03% |
+680,400
| New | +$7.59M |
|
|
DGL
517
DELISTED
Invesco DB Gold Fund
DGL
| $7.5M | 0.03% |
189,785
+2,710
| +1% | +$112K |
|
518
KRONOS Worldwide
KRO
$941M
| $7.47M | 0.03% |
331,500
+80,100
| +32% | +$1.91M |
|
519
Public Storage
PSA
$55.4B
| $7.43M | 0.03% |
32,749
+5,956
| +22% | +$1.24M |
|
520
The GEO Group
GEO
$4.11B
| $7.42M | 0.03% |
269,300
-73,000
| -21% | -$1.74M |
|
|
XHR
521
Xenia Hotels & Resorts
XHR
$1.61B
| $7.39M | 0.03% |
303,527
-54,870
| -15% | -$1.25M |
|
522
Yext
YEXT
$632M
| $7.3M | 0.03% |
377,397
+132,108
| +54% | +$2.03M |
|
523
Outfront Media
OUT
$4.95B
| $7.29M | 0.03% |
380,584
+24,180
| +7% | +$460K |
|
524
Reinsurance Group of America
RGA
$16.2B
| $7.26M | 0.03% |
54,392
+16,070
| +42% | +$2.4M |
|
525
iShares MSCI Japan ETF
EWJ
$23.3B
| $7.25M | 0.03% |
125,270
-68,000
| -35% | -$4.1M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.